Conference abstractPublished 30 Jul 2017
A Major Early Driver Of Tauopathy And Neurodegeneration That Is Blocked By Antibody
Royan Institute for Stem Cell Biology and Technology, Iran
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives Traumatic brain injury (TBI) is one of the major risk factor for Alzheimer’s disease (AD), whose pathological hallmarks include tau hyperphosphorylation. However, so far tauopathy has been undetectable acutely after TBI and how TBI leads to tauopathy which in turn would increase risk of AD remains unknown. We herein identify a neurotoxic cis conformation of phosphorylated tau at Thr231 as a major early driver of tauopathy and neurodegeneration that is effectively blocked by the conformation specific monoclonal antibody. Methods We immunostained control and human TBI brains with our cis/trans monoclonal antibodies. Also, we examined TBI mouse models treated with either control IgG or cis mAb employing immunostaining and electron microscopy. Moreover, we studied risk-taking behaviour of those TBI mice. Results We found robust cis p-tau after sport- and military-related TBI in humans and mice. Acutely after TBI in mice, neurons prominently produce cis p-tau, which disrupts axonal microtubule network, spreads to other neurons, and leads to apoptosis, a pathogenic process, which we termed “cistauosis” that appears long before known tauopathy. Also, while TBI causes abnormal risk-taking behaviour in mouse models, cis antibody treatment restores the phenomena. Conclusions Treating TBI mice with cis antibody prevents tauopathy development and spread, and restores brain histopathological and functional outcomes. These results uncover cistausosis as an early driver of tauopathy and neurodegeneration upon TBI. We anticipate that cis p-tau will be a new early biomarker and that cis p-tau antibody may be used to treat or even prevent TBI, chronic traumatic encephalopathy and AD.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectImmunology & Microbiology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Koorosh Shahpasand”